;Tg INS-Alb-Mut kidneys identified numerous biomarkers, including lipocalin-2, which was then used to monitor the response of the GFR to antioxidant therapy in the mouse model. Renal biopsies and biomarker analysis from a large and diverse patient cohort (ClinicalTrials.gov identifier: NCT00078078) precisely replicated the findings in the animals, establishing Mut −/− ; Tg INS-Alb-Mut mice as a unique model of MMA renal disease. Our studies suggest proximal tubular mitochondrial dysfunction is a key pathogenic mechanism of MMA-associated kidney disease, identify lipocalin-2 as a biomarker of increased oxidative stress in the renal tubule, and demonstrate that antioxidants can attenuate the renal disease of MMA.
cobalamin | chronic renal failure | megamitochondria | organic acidemia R enal tubular dysfunction with progression into chronic tubulointerstitial nephritis (CTIN) and end stage renal disease (ESRD) is a cardinal manifestation of methylmalonic acidemia (MMA), a common and severe organic acidemia characterized by metabolic instability, multisystemic complications, and high mortality (1, 2) . Isolated MMA is primarily caused by mutations in the vitamin B 12 -dependent, mitochondrial matrix-localized methylmalonyl-CoA mutase (MUT), an enzyme that mediates the entry of carbon skeletons derived from branched-chain amino acid, odd-chained fatty acid, and cholesterol oxidation into the Krebs cycle (3) . Although the MUT enzyme is expressed ubiquitously, the clinical features observed, such as pancreatitis, metabolic "stroke" of the globus pallidus, optic nerve atrophy, immune dysfunction, and especially renal disease, indicate a tissue-specific vulnerability in this metabolic disorder. There are no treatments available for MMA other than dietary management and symptomatic care, although liver, kidney, and combined liver-kidney transplantation have been used in the severely affected patients (3) . Kidney disease in MMA can manifest with proximal and/or distal tubular dysfunction and is associated with progressive tubulointerstitial disease (1, 4) , eventually leading to ESRD in >50% of those with severe forms of MMA by the age of 8 y (5). Although renal disease can be present as early as 18 mo (6), the decreased muscle mass seen in the patients (1, 7) renders routine laboratory markers, such as creatinine, poorly predictive of kidney involvement early in disease evolution.
Patients with MMA who have been treated by orthotopic liver transplantation display metabolic stability yet develop extrahepatic disease, including ESRD, and, therefore, provide a clinical paradigm for the development of animal models to study the renal pathophysiology of MMA (8) . In the present work, we have used transgenesis to create Mut −/− mice that express Mut in hepatocytes under the control of the mouse albumin promoter (Mut
). These mice are protected from the neonatal lethality that characterizes the Mut −/− mice (9, 10) but manifest CTIN and a decreased glomerular filtration rate (GFR) associated with megamitochondria formation (11) and decreased cytochrome c oxidase (COX) activity in the proximal tubules. The murine studies prompted the search for similar pathology in kidney biopsies from MMA patients and suggested a therapeutic approach directed at alleviating mitochondrial dysfunction. Genomic and biochemical characterization of disease progression in the Mut −/− ;Tg INS-Alb-Mut mice identified >50 biomarkers associated with MMA renal disease, including lipocalin-2 (Lcn2), that
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Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE41044). was subsequently validated in a large cohort of MMA patients. A therapeutic regimen, directed at reducing oxidant injury with CoQ 10 and vitamin E (VitE), ameliorated the loss of GFR in the Mut −/− ;Tg INS-Alb-Mut mice and was predicted by plasma Lcn2 concentrations. Our studies establish LCN2 as a biomarker of oxidative stress and renal mitochondrial dysfunction and define an approach for the treatment and monitoring of kidney disease in patients with MMA.
Results
Hepatic Expression of Mut Provides Phenotypic Attenuation in Mut −/− Mice. A construct was engineered to express the Mut gene under the control of the chimeric murine minimal albumin promoter and α-fetoprotein enhancer (Fig. S1 A and B) . Three transmitting C57BL/6 Tg INS-Alb-Mut founder lines were established and crossed to C57BL/6 Mut +/− mice (9, 12) . To accelerate the development of extrahepatic manifestations, the lowest expressing line was selected for further study. Mut −/− ;Tg INS-Alb-Mut mice were uniformly rescued from neonatal lethality (Fig. 1A) and appeared comparable to their heterozygote littermates (Fig. 1B) . Immunoreactive Mut protein was detected only in the liver of the Mut −/− ;Tg INS-Alb-Mut mice and was expressed at levels comparable to mRNA expression ( Fig. 1C and Fig. S1C ). [1-
13 C]Propionate oxidative capacity (13) (Fig. 1D) . Despite the grossly normal phenotype, the animals displayed elevated plasma MMA levels (825. To recapitulate the renal disease observed in some patients postliver transplantation with liberalized protein intake (8), the mice were fed a high-protein (HP) (casein) chow. A dietary challenge study for 6 mo (n = 8) was performed in female Mut ;Tg INS-Alb-Mut mice compared with baseline values and P < 0.0001 compared with heterozygotes) (Fig. S3B ). Studies in plasma vs. brain tissue extracts, obtained 2 mo after HP diet in a separate group of mice, showed significantly higher methylmalonic acid concentrations in the brain tissue compared with mice fed regular chow (RD) (Fig. S3 C and D; n = 6 per group; P = 0.007), similar to the trend in plasma. These concentrations closely approximate methylmalonic acid levels observed in our MMA patient cohort at baseline and after the onset of kidney failure in the older subgroup, respectively (Table S1 ). ;Tg INS-Alb-Mut mice appeared normal, and the podocyte foot processes were not effaced ( Fig. 2 Ac vs. Ad). In contrast to the striking renal pathology observed in Mut −/− ;Tg INS-Alb-Mut mice, there were no light or electron microscopic abnormalities in the liver, despite the prolonged exposure to HP and the massive (greater than 1,000× increased) plasma methylmalonic acid concentrations (Fig. S2B) . To determine whether kidneys have a different susceptibility to methylmalonic acid than liver, we administered 20 mg/100 g body weight of methylmalonic acid via daily i.p. injections for 2 mo to wild-type mice. Nephrotoxicity was not observed (Fig. S4 A  and B) .
In parallel to the murine studies, we collected kidney biopsies or explants from three MMA patients enrolled in a natural history study (ClinicalTrials.gov identifier: NCT00078078), who were undergoing solid-organ transplantation. The microscopic findings in the MMA patient kidneys closely resembled the changes seen in the Mut −/− ;Tg INS-Alb-Mut mice (Fig. S3 E vs. F), whereas electron microscopic examination revealed similarly enlarged mitochondria in the proximal tubule, with increased electron-dense matrix and shortened, abnormal cristae (Fig. 2B) . After ingesting a HP diet for 2 mo, the Mut
;Tg INS-Alb-Mut mice manifested significant weight loss, increased mortality, and massively elevated plasma methylmalonate concentrations. We, therefore, selected this time point to measure the GFR using FITClabeled inulin clearance and to assess proximal tubular function. Mut −/− ;Tg INS-Alb-Mut animals showed a significant reduction in GFR (42.1 ± 3.35%; n = 11; P < 0.0001) compared both to the (Fig. 3A) . We observed no differences between male and female GFRs (Fig. S4E) ; however, an increase in serum creatinine was evident in male (P = 0.003) but not in female Mut S5B ). Histology and ultrastructure of the kidneys in both Mut −/− ; Tg INS-Alb-Mut male and female mice did not reveal any significant differences compared with heterozygotes at this time point (Fig. S5E) .
Measurements of single-nephron (SN) GFR and tubular function were performed on anesthetized male mice fed RD because male Mut (Fig. 3B) , and this reduction was accompanied by a parallel diminution of the proximal tubule fluid reabsorption rate (Fig. 3C) . However, there was also a significantly lower fractional fluid reabsorption in the Mut −/− ;Tg INS-Alb-Mut mice, indicating reduced reabsorptive capacity of the proximal tubule, that was independent of the GFR (Fig. 3D ). Blood and urine collected during the micropuncture SNGFR studies also showed a lower plasma bicarbonate and higher chloride concentration in the Mut
−/−
;Tg INS-Alb-Mut mice compared with controls, consistent with chronic hyperchloremic metabolic acidosis. Despite the metabolic acidosis, urinary ammonium excretion was not increased (Table S2) , an expected observation in the setting of renal tubular acidosis (14) . Whole-body GFR studies on RD were not significantly decreased up until 9 mo to 1 y of age (Fig.  S4 C and D) , suggesting that liver-restricted expression of Mut may offer protection from renal failure unless the pathway is challenged by an increased propiogenic load. ;Tg INS-Alb-Mut mice experienced significant growth failure and plasma MMA concentrations of 1,938 ± 418 μmol/L after 6 mo on HP diet (Fig. S3) . (A) Transmission EM showed enlarged mitochondria with whorl-like cristae (Aa vs. Ab; white arrows, mitochondria; white asterisks, brush border of the proximal tubule). Glomeruli appeared normal (Ac and Ad; white asterisks, podocyte foot processes). (B) Transmission EM of patient kidneys showed enlarged mitochondria with disorganized cristae. There were also large remnant vacuoles that contained amorphous membranous inclusions (white arrows, mitochondria; white asterisks, brush border of the proximal tubule; black arrow, vacuoles). (Scale bars: 1 μm.) (Fig. 3E) . The enzymatic activities of the respiratory-chain complexes in both liver and kidney protein extracts showed no significant differences (Table S3) . Furthermore, we measured levels of CoQ, isoforms 9 and 10, to examine whether a primary or secondary synthetic defect might be associated with the mitochondrial abnormalities observed. Mut −/− ;Tg INS-Alb-Mut mice fed a HP diet for 2 mo showed significantly lower CoQ 10 levels than their heterozygote littermates (P < 0.001) (Table S4) ; however, CoQ 9 levels were comparable, suggesting that the biosynthetic capacity for CoQ was preserved in the mutant kidneys. (18) . A sexually dimorphic expression was observed for Cyp4a isoforms (Fig. S5 F-I ). To confirm the induction of Lcn2 observed in the microarray studies, Lcn2 was measured in both mice and patients. Plasma concentrations of Lcn2 in the Mut −/− ;Tg INS-Alb-Mut mice after 2 mo of ingesting a HP chow were elevated (260.7 ± 59.7% of the mean Lcn2 in heterozygotes on RD) compared with their littermates (100 ± 6.05%; P = 0.0004) (Fig. 4A) . Moreover, an increased expression of Lcn2 correlated with the severity of chronic kidney disease, as demonstrated by the inverse correlation of Lcn2 plasma levels with GFR (r = −0.533; n = 19; P = 0.016) (Fig. 4B) . Lcn2 correlated with the decreased GFR even in female animals [r = −0.52; P = not significant (NS)], despite the normal creatinine levels and a much milder phenotype, suggesting that Lcn2 is an early biomarker of the renal dysfunction in Mut ;Tg INS-Alb-Mut mice (r = 0.712; n =14; P = 0.0063). We next sought to validate these biomarkers in a cohort of patients with MMA (n = 46), enrolled in a dedicated natural history study. We documented significant correlations between LCN2 and serum markers of renal function including creatinine (Fig. S6A) , cystatin-C (Fig. S6B) , and estimated GFR (Fig. S6C) , as well as markers of oxidant stress, including plasma oxidized LDL (Fig.  S6D ) and urinary F2iPs (Fig. S6E) . No correlation was observed between LCN2 and dietary protein intake (grams per kilogram body weight per day) of complete or deficient protein and serum total protein or albumin concentrations (grams per deciliter) (Fig. S6 F and G) . mice, we included 0.5% wt/wt ubiquinone, a highly bioavailable form of CoQ 10 , and 0.2% wt/wt VitE in the HP mouse chow. This regimen has been used previously with success to treat an isolated case of MMA with optic nerve atrophy (19) , whereas the dose and formulation of CoQ 10 was identical to that shown to significantly decrease oxidative stress and increase survival in a mouse model of Huntington disease (20) . While Mut −/− ;Tg
INS-
Alb-Mut mice fed a HP diet lost >25% of their weight after 3 d, those that consumed the same diet plus antioxidants showed a trend toward increased survival and decreased weight loss (Fig .  S5 C and D; P = NS and 0.013, respectively). Moreover, the CoQ 10 /VitE-treated mice (n = 6) showed a significantly improved GFR (215.08 ± 57.01 μL/min or 58.6 ± 4.94% heterozygote GFR from 151.22 ± 37.6 μL/min or 42.1 ± 3.35% on HP diet, which represents a 42.2% improvement in absolute numbers, or 16.5% improvement in percent heterozygote GFR) vs. mice on HP diet (n = 11; P = 0.0128; Fig. 5A ). The improvement in the measured GFR was accompanied by a total abrogation of increased plasma Lcn2 levels and a reduction in Lcn2 mRNA expression in the kidney of the CoQ 10 /VitE-treated Mut −/− ; Tg INS-Alb-Mut mice ( Fig. 5 B and C) , as well as by the normalization of the increased plasma creatinine concentrations seen in males (Fig. 5D ). The decrease in Lcn2 was paralleled by a similar decrease in urinary F2iPs (Fig. 5E) . On the other hand, (11) in the face of >1,000× elevated plasma methylmalonic acid concentrations suggests that the cellular phenotype could be rescued by tissuespecific expression of Mut (Fig. S2B) . Moreover, a significant functional improvement in the GFR was observed in the CoQ 10 / VitE treated Mut −/− ;Tg INS-Alb-Mut mice despite the continuous exposure of the kidneys to a HP diet and elevated circulating metabolites (Fig. 5 A and F) , whereas daily i.p. administered methylmalonic acid for 2 mo did not have significant nephrotoxic effects in wild-type mice (Fig. S4A) . Together, these findings suggest that cell and/or mitochondrial autonomous effects, rather than elevations in methylmalonic acid per se, are responsible for the hepatic mitochondrial changes and the GFR decrease associated with proximal tubular mitochondrial dysfunction. This challenges previous theories about methylmalonate as a toxic agent (21, 22) and further supports observations from gene therapy studies showing that the long-term correction of Mut −/− mice is mediated by a small number of stably transduced cells (13, 23) . The concept that a kidney with normal Mut activity may be protected from MMA nephrotoxicity is reinforced by a recent study that proposed providing renal allografts as a form of "cellular" therapy for MMA, despite the implicit knowledge that the allograft will be exposed to very high metabolite concentrations in the recipient patient (24) . Further support of a cell-autonomous effect was demonstrated by the local production of methylmalonic acid in the brain tissue on HP diet (Fig. S3D) , as well as by the focal decrease in COX in a subset of the Mut −/− ;Tg INS-Alb-Mut tubules (Fig. 3E) , with no obvious impairment in respiratory-chain complex activities analyzed in whole kidney extracts, similar to what is observed in the skeletal muscle of patients with mitochondrial myopathies (25) . Given that HP seems necessary for the progression of chronic renal disease in our model (Fig. S4 C and D) , we suggest that both mitochondrial dysfunction and toxic metabolite accumulation play a role in disease pathophysiology; hence, conditional cell-autonomy more accurately reflects the current findings.
Gene-expression profiling on whole kidneys collected 2 mo after initiating a HP diet revealed significant enrichment in several inflammatory, signaling, and metabolic pathways. A number of gene-targets of the retinoid X receptor/peroxisome proliferator-activated receptor α (PPARα), including Cyp4a12a and -b, Fabp1, and Hmgcs2, were up-regulated, consistent with the pronounced number of mitochondria in the tubules of patients and mice. Biomarkers of acute and chronic kidney injury, Havcr1 (KIM-1) and Lcn2 (neutrophil gelatinase-associated lipocalin), were up-regulated in the Mut −/− ;Tg INS-Alb-Mut kidneys. Lcn2, originally identified as a 25-kDa protein associated with neutrophil gelatinase (26) , is largely produced by the tubular epithelium of the distal nephron after cellular damage and is associated with acute kidney injury (15) , as well as chronic kidney disease progression (27) . The murine and patient studies presented here demonstrate a strong correlation of Lcn2 with markers of oxidative stress. Moreover, Lcn2 mRNA expression in the tissue and its resulting plasma concentrations were reduced after the administration of antioxidants, supporting a link between oxidative stress and Lcn2 in the renal disease of MMA and potentially other forms of tubulointerstitial nephritis associated with mitochondrial dysfunction.
The proximal tubular dysfunction was further validated by micropuncture studies of single Mut −/− ;Tg INS-Alb-Mut nephrons (Fig. 3 B-D) that demonstrated aberrant ammonium excretion in the presence of hyperchloremic metabolic acidosis (Table S2 ). The diminished GFR can thus be viewed as protective, because it reduces the absorptive load upon the functionally impaired proximal tubule cells. Although it is unclear which exact mechanism(s) underlies the drastic reduction of GFR, single-nephron measurements documented a functional impairment well before any overt structural or ultrastructural changes in the tubules or , and urine F2iPs improved after antioxidant therapy (P = NS compared with treated heterozygote mice) (E), despite the persistence of elevated serum MMA levels (P < 0.0001 between mutant and heterozygote mice on either diet) (F). Data are presented as means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 (Kruskal-Wallis test).
